Your browser doesn't support javascript.
loading
Randomized Controlled Trial of a Nurse-Led Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer.
Greer, Joseph A; Post, Kathryn E; Chabria, Reena; Aribindi, Seetha; Brennan, Natalie; Eche-Ugwu, Ijeoma Julie; Halpenny, Barbara; Fox, Erica; Lo, Stephen; Waldman, Lauren P; Pintro, Kedie; Rabideau, Dustin J; Pirl, William F; Cooley, Mary E; Temel, Jennifer S.
Afiliação
  • Greer JA; Massachusetts General Hospital, Boston, MA.
  • Post KE; Harvard Medical School, Boston, MA.
  • Chabria R; Massachusetts General Hospital, Boston, MA.
  • Aribindi S; Harvard Medical School, Boston, MA.
  • Brennan N; Massachusetts General Hospital, Boston, MA.
  • Eche-Ugwu IJ; Massachusetts General Hospital, Boston, MA.
  • Halpenny B; Massachusetts General Hospital, Boston, MA.
  • Fox E; Harvard Medical School, Boston, MA.
  • Lo S; Dana-Farber Cancer Institute, Boston, MA.
  • Waldman LP; Dana-Farber Cancer Institute, Boston, MA.
  • Pintro K; Dana-Farber Cancer Institute, Boston, MA.
  • Rabideau DJ; Massachusetts General Hospital, Boston, MA.
  • Pirl WF; Harvard Medical School, Boston, MA.
  • Cooley ME; Brigham and Women's Hospital, Boston, MA.
  • Temel JS; Massachusetts General Hospital, Boston, MA.
J Clin Oncol ; : JCO2400048, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-39088766
ABSTRACT

PURPOSE:

In patients with lung cancer, dyspnea is one of the most prevalent and disabling symptoms, for which effective treatments are lacking. We examined the efficacy of a nurse-led brief behavioral intervention to improve dyspnea in patients with advanced lung cancer.

METHODS:

Patients with advanced lung cancer reporting at least moderate breathlessness (n = 247) were enrolled in a randomized trial of a nurse-led two-session intervention (focused on breathing techniques, postural positions, and fan therapy) versus usual care. At baseline and weeks 8 (primary end point), 16, and 24, participants completed measures of dyspnea (Modified Medical Research Council Dyspnea Scale [mMRCDS]; Cancer Dyspnoea Scale [CDS]), quality of life (Functional Assessment of Cancer Therapy-Lung [FACT-L]), psychological symptoms (Hospital Anxiety and Depression Scale), and activity level (Godin-Shephard Leisure Time Physical Activity Questionnaire). To examine intervention effects, we conducted analysis of covariance and longitudinal mixed effects models.

RESULTS:

The sample (Agemean = 66.15 years; 55.9% female) primarily included patients with advanced non-small cell lung cancer (85.4%). Compared with usual care, the intervention improved the primary outcome of patient-reported dyspnea on the mMRCDS (difference = -0.33 [95% CI, -0.61 to -0.05]) but not the CDS total score at 8 weeks. Intervention patients also reported less dyspnea on the CDS sense of discomfort subscale (difference = -0.59 [95% CI, -1.16 to -0.01]) and better functional well-being per the FACT-L (difference = 1.39 [95% CI, 0.18 to 2.59]) versus the control group. Study groups did not differ in overall quality of life, psychological symptoms, or activity level at 8 weeks or longitudinally over 24 weeks.

CONCLUSION:

For patients with advanced lung cancer, a scalable behavioral intervention alleviated the intractable symptom of dyspnea. Further research is needed on ways to enhance intervention effects over the long-term and across additional outcomes.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Marrocos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Marrocos